第24回あわじ感染と免疫国際フォーラム

○Ifeanyi Theodora Ndubuisi¹, Lilian Chepgetich Koech¹, Satoshi Kaneko¹, Yoshimasa Tanaka² (1. Institute of Tropical Medicine, Nagasaki University (Japan), 2. Center for Medical Innovation, Nagasaki University (Japan))

○Yadya M Chawla¹, M Jeeva Sankar², Murali-Krishna Kaja^1,3, Anmol Chadele¹ (1. International Centre for Genetic Engineering and Biotechnology (India), 2. All India Institute of Medical Sciences (India), 3. Emory University (USA))

○Yoji Mori¹, Nanao Fujitani¹, Manel Nicolas², Kimiko Kuroki¹, Katsumi Maenaka^1,3,4,5 (1. Faculty of Pharmaceutical Sciences, Hokkaido University (Japan), 2. Institut Curie (France), 3. Inter. Inst. Zoonosis Control, Hokkaido Univ. (Japan), 4. Inst. Vaccine Res. & Devel., Hokkaido Univ. (Japan), 5. Facul. Pharm. Sci., Kyushu Univ. (Japan))

○Dinara Turebekova¹, Irina Kadyrova¹, Zhaniya Dauletkaliyeva², Dmitriy Solyanov¹, Shynar Muratbekova³ (1. The Scientific Research Laboratory, Institute of Life Sciences, Karaganda Medical University, Karaganda, Kazakhstan (Kazakhstan), 2. School of Public Health, Karaganda Medical University, Karaganda, Kazakhstan (Kazakhstan), 3. Department of Neurology, Psychiatry and Rehabilitation, Karaganda Medical University, Karaganda, Kazakhstan (Kazakhstan))

○Thitinan Kitisin¹, Thananya Jinato², Nilnetre Mahathanaruk³, Jetsumon Sattabongkot², Lisa E. Wagar^4,5,6 (1. Department of Microbiology and Immunology, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand (Thailand), 2. Mahidol Vivax Research Unit, Faculty of Tropical Medicine, Mahidol, University, Bangkok, Thailand (Thailand), 3. Department of Otolaryngology-Head and Neck Surgery, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand (Thailand), 4. Department of Physiology & Biophysics, University of California, Irvine, Irvine, CA, USA (USA), 5. Institute for Immunology, University of California, Irvine, Irvine, CA, USA (USA), 6. Center for Virus Research, University of California, Irvine, Irvine, CA, USA (USA))

○Steven Matthew Heaton¹, Shohei Kojima^1,2, Miki Kojima¹, Tomoko Kasahara¹, Hiromi Sano¹, Fumie Yokoyama¹, Anselmo Jiro Kamada^1,3, Rie Koide¹, Asami Fujii Gelinas¹, Takashi Watanabe¹, Takaho Endo¹, Yoshinari Ando¹, Kokoro Ozaki¹, Yasuhiro Murakawa¹, Chikashi Terao¹, Nicholas Fredrick Parrish^1,4 (1. RIKEN Center for Integrative Medical Sciences (Japan), 2. Keio University (Japan), 3. University of Oxford Department of Biology (UK), 4. Duke University Department of Surgery (USA))

○Tsutomu Tanaka^1,2, Torsten B. Meissner^3,4, Saptha Vijayan⁵, Kyoung-Hee Lee^3,4, Yuen-Joyce Liu³, Isaac Downs⁵, Jason Yeung⁵, Koichi S. Kobayashi^1,2,5 (1. Dept. of Immunol., Faculty of Med. and Grad. Sch. of Med., Hokkaido Univ. (Japan), 2. The Institute for Vaccine Research and Development (IVReD), Hokkaido University (Japan), 3. Department of Cancer Immunology & AIDS, Dana-Farber Cancer Institute, Boston, MA (USA), 4. Department of Microbiology and Immunobiology, Division of Immunology, Harvard Medical School, Boston, MA (USA), 5. Department of Microbial Pathogenesis and Immunology, Texas A&M Health Science Center, College Station, TX (USA))

○Thananya Jinato¹, Sadudee Chotirat¹, Ammarind Anatjitsupha¹, Wanlapa Roobsoong¹, Jetsumon Sattabongkot¹ (1. Mahidol Vivax Research Unit, Faculty of Tropical Medicine, Mahidol, University, Bangkok, Thailand (Thailand))

○Sandra Steffany Morales Ruiz¹, Natsuko Shimazaki¹, Mai Otsuki¹, Hisatoshi Shida¹, Tomoyuki Miura¹ (1. Primate Model laboratory, Institute for Life and Medical Sciences, Kyoto University (Japan))

○Khoir AMALIIN^1,2, Mansaku HIRAI^1,2, Salma AKTAR¹, Tetsuo KOSHIZUKA³, Yasuko MORI¹, Jun ARII^2,1 (1. Division of Clinical Virology, Center for Infectious Diseases, Kobe University Graduate School of Medicine, Kobe (Japan), 2. Department of Virology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima (Japan), 3. Department of Microbiology and Immunology, Gifu Pharmaceutical University, Gifu (Japan))

○Zufang Wu¹, Yuichi Igarashi^1,2, Tsutomu Tanaka^1,2, Yusuke Kasuga^1,2, Koichi Kobayashi^1,2,3 (1. Department of Immunology, Hokkaido University Graduate School of Medicine (Japan), 2. Hokkaido University Institute for Vaccine Research and Development, (Japan), 3. Department of Microbial Pathogenesis and Immunology, Texas A&M University (USA))

Keiko Matsuura¹, Anton Kratz¹, Micheal Pillay¹, Kaidre Bendjama^1,2, ○Sebastian Kapell^1,2 (1. Dept. of Vacc. Inform., Inst. of Trop. Med., Nagasaki Univ. (Japan), 2. NEC Oncoimmunity (Norway))

○Jordan Villa¹, Ken Suzawa², Tatsuhiko Ikeda¹, Yosuke Togashi³, Kazuo Yamashita¹ (1. KOTAI Biotechnologies, Inc (Japan), 2. Okayama University, Graduate School of Medicine, Department of General Thoracic Surgery and Breast and Endocrinological Surgery (Japan), 3. Okayama University, Graduate School of Medicine, Department of Tumor Microenvironment (Japan))

○Bo-Nian Chen¹, Wei-Yang Sit¹, Wen-Ching Wang¹ (1. National Tsing Hua University (Taiwan))